ATORVASTATIN XANTIS

40MG TBL FLM 30

SPC - Summary of product characteristics atorvastatin-xantis-spc.pdf
NR - Registration decision NR4048115.pdf
PIL - Package leaflet atorvastatin-xantis-pil.pdf
PAR - Public assessment report  
Text on the wrap atorvastatin-xantis-obal.pdf
Braills Approved – name of the medicinal product in Braille on the packaging was confirmed.
SPCs and PILs of centralised medicinal products (registration number beginning EU) are included as a link to website of the European Medicines Agency (EMEA) Information is available on this website in section Product Information. Please note that the texts refer to all strenghts and pharmaceutical forms of the given medicinal product. SUKL is not responsible for update SPCs and PILs on EMEA web site.

EAN – more specific information about EAN code is available in the Overview

Back to list